Published by mark itwired
Posted on September 29, 2021
The global ibuprofen API market surpassed US$ 572.9 Mn in 2019 and is set for a stable growth outlook over the course of 2019 – 2029, as per the findings of a new Future Market Insights (FMI) study. The primary factors for growth of the Ibuprofen API market include continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID), and scale and age of manufacturing facilities.
Increasing API drug shortages and assembling task force to overcome these problems, emergence of cost-effective drug manufacturers in various countries and supply of API drugs, primarily in developing countries, are further driving ibuprofen API market growth.
The pharmaceutical API industry is witnessing a substantial crunch in supply and demand of Ibuprofen API, halted production from major ibuprofen API manufactures, supply chain disruption in china further led by declining sale in India. The volatility in Ibuprofen API is due to factors such as lower number of competitors, reduced utilization ratio, lower margin level, new higher-value opportunities in complex combinations and high-grade API, pace of facility inspection by FDA, and ramping up production capacity of through mergers and consolidation.
FMI’s analysis suggests that the ongoing COVID-19 pandemic is having adverse impacts on market growth. Wuhan, China is the hub of API supplies. The region is the epicenter of the coronavirus outbreak, as such, it has temporarily halted its manufacturing facilities. Further, China is the prominent or the sole supplier of APIs including, penicillin and erythromycin, in the world. Manufacturers and distributors in the country are blaming logistical barriers and labor scarcity due to the COVID-19 pandemic for delay in production and transportation.
Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11260
Lower labor cost, abundant availability of raw materials required to ibuprofen API are among the key factors fueling the growth of ibuprofen API market in South Asia. In addition, favorable regulatory support to establish ibuprofen API manufacturing businesses, lower taxation policies are boosting the growth of East and South Asia ibuprofen API market.
Leading players in ibuprofen API market – SI Group, Inc., BASF SE, Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited – are focusing on business expansions by mergers, joint ventures, distribution agreements and capturing the untapped potential of the Ibuprofen API market.
Additionally, current acquisitions are focused on capacity expansion, and manufacturing capabilities of existing Ibuprofen API players in order to gain competitiveness and accelerate revenue growth in the market landscape.
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The global Ibuprofen API market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on Ibuprofen API market on basis of by end user (Contract Manufacturing Organization and Pharmaceutical Companies), across seven major regions.
Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-11260
1.1. Global Market Outlook
1.2. Trends
1.3. Technology Roadmap
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
3.3. Strategic Promotional Strategies, By Key Manufacturers
4.1. Product USPs/ Features
4.2. Region wise Consumption
4.3. Regulatory Scenario
5.1. Historical Market Volume (TPA) Analysis, 2014-2018
5.2. Current and Future Market Volume (TPA) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Opportunity Analysis, 2019-2029
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Outlook
6.2. Forecast Factors – Relevance & Impact
6.2.1. Research and Developmental Activities
6.2.2. Technological Advancement
6.2.3. Adoption of Ibuprofen API
6.2.4. Cost of production
6.2.5. Supply chain
6.2.6. Focus of Manufacturer to increase capacity
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunities
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
7.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Opportunity Analysis, 2019-2029
The post Ibuprofen API Market Growth Prospects, Research, Overview And Competitive Landscape 2029 first appeared on Market Research Blog.
The global ibuprofen API market surpassed US$ 572.9 Mn in 2019 and is set for a stable growth outlook over the course of 2019 – 2029, as per the findings of a new Future Market Insights (FMI) study. The primary factors for growth of the Ibuprofen API market include continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID), and scale and age of manufacturing facilities.
Increasing API drug shortages and assembling task force to overcome these problems, emergence of cost-effective drug manufacturers in various countries and supply of API drugs, primarily in developing countries, are further driving ibuprofen API market growth.
The pharmaceutical API industry is witnessing a substantial crunch in supply and demand of Ibuprofen API, halted production from major ibuprofen API manufactures, supply chain disruption in china further led by declining sale in India. The volatility in Ibuprofen API is due to factors such as lower number of competitors, reduced utilization ratio, lower margin level, new higher-value opportunities in complex combinations and high-grade API, pace of facility inspection by FDA, and ramping up production capacity of through mergers and consolidation.
FMI’s analysis suggests that the ongoing COVID-19 pandemic is having adverse impacts on market growth. Wuhan, China is the hub of API supplies. The region is the epicenter of the coronavirus outbreak, as such, it has temporarily halted its manufacturing facilities. Further, China is the prominent or the sole supplier of APIs including, penicillin and erythromycin, in the world. Manufacturers and distributors in the country are blaming logistical barriers and labor scarcity due to the COVID-19 pandemic for delay in production and transportation.
Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11260
Lower labor cost, abundant availability of raw materials required to ibuprofen API are among the key factors fueling the growth of ibuprofen API market in South Asia. In addition, favorable regulatory support to establish ibuprofen API manufacturing businesses, lower taxation policies are boosting the growth of East and South Asia ibuprofen API market.
Leading players in ibuprofen API market – SI Group, Inc., BASF SE, Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited – are focusing on business expansions by mergers, joint ventures, distribution agreements and capturing the untapped potential of the Ibuprofen API market.
Additionally, current acquisitions are focused on capacity expansion, and manufacturing capabilities of existing Ibuprofen API players in order to gain competitiveness and accelerate revenue growth in the market landscape.
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The global Ibuprofen API market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on Ibuprofen API market on basis of by end user (Contract Manufacturing Organization and Pharmaceutical Companies), across seven major regions.
Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-11260
1.1. Global Market Outlook
1.2. Trends
1.3. Technology Roadmap
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
3.3. Strategic Promotional Strategies, By Key Manufacturers
4.1. Product USPs/ Features
4.2. Region wise Consumption
4.3. Regulatory Scenario
5.1. Historical Market Volume (TPA) Analysis, 2014-2018
5.2. Current and Future Market Volume (TPA) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Opportunity Analysis, 2019-2029
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Outlook
6.2. Forecast Factors – Relevance & Impact
6.2.1. Research and Developmental Activities
6.2.2. Technological Advancement
6.2.3. Adoption of Ibuprofen API
6.2.4. Cost of production
6.2.5. Supply chain
6.2.6. Focus of Manufacturer to increase capacity
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunities
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
7.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Opportunity Analysis, 2019-2029
The post Ibuprofen API Market Growth Prospects, Research, Overview And Competitive Landscape 2029 first appeared on Market Research Blog.
